...

首页> 外文期刊>Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation >Role of Hematopoietic Cell Transplantation Co-Morbidity Index (HCT-CI) in Selection of Conditioning Regimen for Patients Undergoing Allogeneic Hematopoetic Cell Transplantation (Allo-HCT) - a Single Institution

【24h】

Role of Hematopoietic Cell Transplantation Co-Morbidity Index (HCT-CI) in Selection of Conditioning Regimen for Patients Undergoing Allogeneic Hematopoetic Cell Transplantation (Allo-HCT) - a Single Institution

机译：造血细胞移植合并症指数（HCT-CI）在接受异基因造血细胞移植（Allo-HCT）的患者的条件治疗方案选择中的作用-单机构

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation》 |2015年第1期|共1页
作者
De Yao Jocelyn; Sadashiv Santhosh; Berteotti Gina; Sahovic Entezam A.; Lister John;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词

相似文献

外文文献
中文文献
专利

1. 静脉剂型白消安为主的预处理方案对接受异基因造血干细胞移植的白血病患者的疗效及相关毒性 [J] . 童秀珍, 许多荣, 邹外一, 癌症（英文版） . 2007,第008期
2. Role of Hematopoietic Cell Transplantation Co-Morbidity Index (HCT-CI) in Selection of Conditioning Regimen for Patients Undergoing Allogeneic Hematopoetic Cell Transplantation (Allo-HCT) - a Single Institution [J] . De Yao Jocelyn, Sadashiv Santhosh, Berteotti Gina, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2015,第2Suppla1期

机译：造血细胞移植合并症指数（HCT-CI）在接受异基因造血细胞移植（Allo-HCT）的患者的条件治疗方案选择中的作用-单机构
3. More Intensive Fludarabine/Busulfan (Flu/Bu) Conditioning Regimens Result in Similar Outcomes Without Adding Serious Toxicity When Compared to Fludarabine/Melphalan (Flu/Mel) in Patients Undergoing Allogeneic Hematopoietic Cell Transplant (Allo-HCT) [J] . Jeremy Pappacena, Valkal Bhatt, Gunjan L. Shah, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2018,第3期

机译：更加强烈的氟纳比林/母艇（Flu / Bu）调理方案导致类似的结果，而不是在接受同种异体造血细胞移植（Allo-Hct）的血糖胺/ Melphalan（Flu / Mel）时添加严重毒性
4. Comparison of Outcomes for Pediatric Patients With Acute Myeloid Leukemia in Remission and Undergoing Allogeneic Hematopoietic Cell Transplantation With Myeloablative Conditioning Regimens Based on Either Intravenous Busulfan or Total Body Irradiation: A Report From the Japanese Society for Hematopoietic Cell Transplantation [J] . Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2015,第12期

机译：小儿急性粒细胞白血病缓解和接受异体造血方案的异体造血细胞移植基于静脉白硫烷或全身照射的结果比较：日本造血细胞移植学会的报告
5. THE EFFECT OF INHIBITORY KILLER-CELL IG-LIKE RECEPTOR (IKIR) MATCHING IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (HCT) [C] . David Senitzer, Joel Y. Sun, Arisa Oki, Clinical Histocompatibility Workshop. . 2009

机译：同种异体造血细胞移植（HCT）中抑制杀伤细胞IG样受体（IKIR）匹配的影响
6. Donor selection for patients undergoing allogeneic hematopoietic stem cell transplantation: Assessment of the priorities of Canadian hematopoietic stem cell transplant physicians. [D] . Tay, Jason. 2009

机译：接受同种异体造血干细胞移植的患者的供体选择：加拿大造血干细胞移植医生的优先事项评估。
7. Impact of the intensity of the pretransplantation conditioning regimen in patients with prior invasive aspergillosis undergoing allogeneic hematopoietic stem cell transplantation: a retrospective survey of the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation [O] . Rodrigo Martino, Rocio Parody, Takahiro Fukuda, -1

机译：移植前条件疗法强度对异基因造血干细胞移植前侵袭性曲霉病患者的影响：对欧洲血液和骨髓移植小组传染病工作组的回顾性调查
8. Role of Hematopoietic Cell Transplantation Co-Morbidity Index (HCT-CI) in Selection of Conditioning Regimen for Patients Undergoing Allogeneic Hematopoetic Cell Transplantation (Allo-HCT) – a Single Institution [O] . De Yao Jocelyn, Sadashiv Santhosh, Berteotti Gina, 2015

机译：造血细胞移植合并症指数（HCT-CI）在接受异基因造血细胞移植（Allo-HCT）的患者的条件治疗方案选择中的作用–单一机构

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号